Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021756

« Back to Dashboard
NDA 021756 describes MACUGEN, which is a drug marketed by Valeant Pharms Llc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the MACUGEN profile page.

The generic ingredient in MACUGEN is pegaptanib sodium. One supplier is listed for this compound. Additional details are available on the pegaptanib sodium profile page.

Summary for NDA: 021756

Valeant Pharms Llc
pegaptanib sodium

Pharmacology for NDA: 021756

Suppliers and Packaging for NDA: 021756

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
pegaptanib sodium
INJECTABLE;INTRAVITREAL 021756 NDA Bausch & Lomb Incorporated 68782-001 68782-001-02 1 SYRINGE in 1 CARTON (68782-001-02) > .09 mL in 1 SYRINGE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVITREALStrengthEQ 0.3MG ACID/0.09ML
Approval Date:Dec 17, 2004TE:RLD:Yes
Patent:5,932,462Patent Expiration:Aug 3, 2016Product Flag?Substance Flag?YDelist Request?
Patent:6,011,020Patent Expiration:Jan 4, 2017Product Flag?Substance Flag?YDelist Request?

Expired Orange Book Patents for NDA: 021756

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms Llc
pegaptanib sodium
INJECTABLE;INTRAVITREAL021756-001Dec 17, 20045,919,455► subscribe
Valeant Pharms Llc
pegaptanib sodium
INJECTABLE;INTRAVITREAL021756-001Dec 17, 20046,051,698► subscribe
Valeant Pharms Llc
pegaptanib sodium
INJECTABLE;INTRAVITREAL021756-001Dec 17, 20046,147,204► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.